Washington—New classes of diabetes drugs that mimic gut hormones may help patients with the disease battle persistent problems that conventional treatments alone are often unable to adequately control.
Even with treatment, patients with diabetes—particularly type 2 diabetes—may face spikes in blood glucose after meals, weight gain, and a loss of effectiveness of their treatments over time. But new agents that draw on a better understanding of how the body responds to meals—some already available, others in the development pipeline—may offer useful adjuncts to existing therapies (Riddle MC and Drucker DJ. Diabetes Care. 2006:29:435-449).
Kuehn BM. New Diabetes Drugs Target Gut Hormones. JAMA. 2006;296(4):380-381. doi:10.1001/jama.296.4.380